ALNY vs WCC · P/E 76, rev $1.29B vs P/E 15, rev $12.75B
Alnylam Pharmaceuticals Inc (ALNY) versus WESCO International Inc (WCC) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
WESCO International Inc (WCC) is a industrial distribution company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported WCC revenue for 2026-06-30 was $12.75B. Net income was $362.8M. WCC currently screens at market cap $9.48B and trailing P/E 14.7.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. WCC currently screens at market cap $9.48B and trailing P/E 14.7.
Not investment advice. Open the ALNY and WCC stock pages for the full models.
Not investment advice.